ENCODE biosample ENCBS050NNR

characteristic: External Id

text: ENCODE

characteristic: INSDC last update

text: live

characteristic: INSDC status

text: Generic

characteristic: SRA accession

text: 53 year

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens CMTR1

text: adult

text: chronic myelogenous leukemia (CML)

text: Brenton Graveley, UConn

characteristic: lab

text: Homo sapiens

text: cell line

text: female

text: ATCC

text: ENCODE biosample ENCBS050NNR: RNA-seq on K562 cells treated with a CRISPR gRNA against CMTR1. (CMTR1-BGKcLV28-25)

characteristic: title


ENCODE biosample ENCBS050QUI

status: PUBLIC

text: ENCODE

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC secondary accession

text: live

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

text: 15 year

tag: attribute

characteristic: age

characteristic: cell line

text: Homo sapiens HepG2 cell line genetically modified (deletion) using CRISPR targeting H. sapiens RUVBL2

characteristic: description

text: child

characteristic: dev stage

characteristic: donor ID

text: hepatocellular carcinoma

characteristic: health state

text: Brenton Graveley, UConn

text: Homo sapiens

characteristic: organism

text: cell line

characteristic: sample type

text: male

characteristic: sex

text: ATCC

characteristic: source

text: ENCODE biosample ENCBS050QUI: RNA-seq on HepG2 cells treated with a CRISPR gRNA against RUVBL2. (RUVBL2-BGHcLV31-22)


ENCODE biosample ENCBS051GWD

characteristic: External Id

text: ENCODE

characteristic: INSDC last update

text: live

characteristic: INSDC status

text: Generic

characteristic: SRA accession

text: 53 year

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens CNDP2

text: adult

text: chronic myelogenous leukemia (CML)

text: Brenton Graveley, UConn

characteristic: lab

text: Homo sapiens

text: cell line

text: female

text: ATCC

text: ENCODE biosample ENCBS051GWD: RNA-seq on K562 cells treated with a CRISPR gRNA against CNDP2. (CNDP2-BGKcLV28-27)


ENCODE biosample ENCBS052NOA

text: ENCODE

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC secondary accession

text: live

text: Generic

characteristic: NCBI submission model

text: 53 year

text: Homo sapiens K562 cell line treated with 10 nM Chaetocin for 24 hours, preserved by flash-freezing

text: adult

text: chronic myelogenous leukemia (CML)

text: Will Greenleaf, Stanford

text: Homo sapiens

text: cell line

text: female

text: ATCC

text: ENCODE biosample ENCBS052NOA: RNA-seq on human cell line K562

characteristic: title

text: treatment_term_name: Chaetocin; treatment_type: chemical; duration: 24; duration_units: hour; temperature: 37; temperature_units: Celsius;

characteristic: treatments


ENCODE biosample ENCBS055NUJ

text: ENCODE

text: live

text: Generic

characteristic: NCBI submission package

text: 15 year

characteristic: age

characteristic: cell line

text: Homo sapiens HepG2 cell line genetically modified (deletion) using CRISPR targeting H. sapiens DCPS

characteristic: description

text: child

characteristic: dev stage

characteristic: donor ID

text: hepatocellular carcinoma

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

text: male

text: ATCC

text: ENCODE biosample ENCBS055NUJ: RNA-seq on HepG2 cells treated with a CRISPR gRNA against DCPS. (DCPS-BGHcLV29-64)


ENCODE biosample ENCBS056ENN

characteristic: External Id

text: ENCODE

text: live

text: Generic

text: 90 or above year

text: Homo sapiens female adult (90 or above years) with mild cognitive impairment; middle frontal area 46 tissue

text: adult

text: Barbara Wold, Caltech

text: Homo sapiens

characteristic: organism

text: tissue

characteristic: sample type

text: female

characteristic: sex

text: Rush University

characteristic: source

text: middle frontal area 46

characteristic: tissue

text: ENCODE biosample ENCBS056ENN: human_brain_Rush ID_E2395615_BS177_ENC4_cDNA731


ENCODE biosample ENCBS056LXD

text: ENCODE

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: live

characteristic: INSDC status

text: Generic

characteristic: SRA accession

text: 53 year

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens CTTN

text: adult

text: chronic myelogenous leukemia (CML)

characteristic: health state

text: Brenton Graveley, UConn

characteristic: lab

text: Homo sapiens

text: cell line

text: female

text: ATCC

text: ENCODE biosample ENCBS056LXD: RNA-seq on K562 cells treated with a CRISPR gRNA against CTTN. (CTTN-BGKcLV28-51)


ENCODE biosample ENCBS059DTN

text: ENCODE

characteristic: INSDC secondary accession

text: live

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

text: 53 year

characteristic: age

characteristic: cell line

text: Homo sapiens K562 cell line

text: adult

text: chronic myelogenous leukemia (CML)

text: John Lis, Cornell

text: Homo sapiens

text: cell line

text: female

text: ATCC

text: ENCODE biosample ENCBS059DTN

characteristic: title


ENCODE biosample ENCBS060LCH

characteristic: External Id

text: ENCODE

text: live

text: Generic

text: 15 year

text: Homo sapiens HepG2 cell line genetically modified (deletion) using CRISPR targeting H. sapiens RPRD1B

characteristic: description

text: child

characteristic: dev stage

characteristic: donor ID

text: hepatocellular carcinoma

text: Brenton Graveley, UConn

text: Homo sapiens

characteristic: organism

text: cell line

characteristic: sample type

text: male

text: ATCC

text: ENCODE biosample ENCBS060LCH: RNA-seq on HepG2 cells treated with a CRISPR gRNA against RPRD1B. (RPRD1B-BGHcLV32-57)


ENCODE biosample ENCBS060QNZ

text: ENCODE

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Generic

text: 15 year

text: Homo sapiens HepG2 cell line genetically modified (deletion) using CRISPR targeting H. sapiens AHCYL2

text: child

text: hepatocellular carcinoma

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

text: male

characteristic: sex

text: ATCC

characteristic: source

text: ENCODE biosample ENCBS060QNZ: RNA-seq on HepG2 cells treated with a CRISPR gRNA against AHCYL2. (AHCYL2-BGHcLV25-21)


ENCODE biosample ENCBS063IQR

text: ENCODE

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

characteristic: SRA accession

text: 53 year

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens AGFG1

text: adult

text: chronic myelogenous leukemia (CML)

characteristic: health state

text: Brenton Graveley, UConn

characteristic: lab

text: Homo sapiens

text: cell line

text: female

text: ATCC

text: ENCODE biosample ENCBS063IQR: RNA-seq on K562 cells treated with a CRISPR gRNA against AGFG1. (AGFG1-BGKcLV26-16)


ENCODE biosample ENCBS065PAT

text: ENCODE

text: live

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

text: 53 year

characteristic: age

characteristic: cell line

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens DDX10

text: adult

text: chronic myelogenous leukemia (CML)

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

text: female

text: ATCC

text: ENCODE biosample ENCBS065PAT: RNA-seq on K562 cells treated with a CRISPR gRNA against DDX10. (DDX10-BGKcLV28-67)

characteristic: title


ENCODE biosample ENCBS068BSV

characteristic: External Id

text: ENCODE

text: live

text: Generic

text: 53 year

text: Homo sapiens K562 cell line treated with 10 nM Chaetocin for 4 hours, preserved by flash-freezing

characteristic: description

text: adult

characteristic: dev stage

characteristic: donor ID

text: chronic myelogenous leukemia (CML)

text: Will Greenleaf, Stanford

text: Homo sapiens

characteristic: organism

text: cell line

text: female

text: ATCC

text: ENCODE biosample ENCBS068BSV: RNA-seq on human cell line K562

text: treatment_term_name: Chaetocin; treatment_type: chemical; duration: 4; duration_units: hour; temperature: 37; temperature_units: Celsius;

characteristic: treatments


ENCODE biosample ENCBS068FIA

text: ENCODE

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Generic

text: 86 year

text: Homo sapiens female adult (86 years) with Cognitive impairment; middle frontal area 46 tissue

text: adult

text: Barbara Wold, Caltech

text: Homo sapiens

text: tissue

characteristic: sample type

text: female

characteristic: sex

text: Rush University

characteristic: source

text: middle frontal area 46

characteristic: tissue

text: ENCODE biosample ENCBS068FIA: human_brain_Rush ID_E3666162_BS197_ENC4_cDNA752


ENCODE biosample ENCBS068MOK

text: ENCODE

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

characteristic: SRA accession

text: 53 year

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens SEPT11

text: adult

text: chronic myelogenous leukemia (CML)

characteristic: health state

text: Brenton Graveley, UConn

characteristic: lab

text: Homo sapiens

text: cell line

text: female

text: ATCC

text: ENCODE biosample ENCBS068MOK: RNA-seq on K562 cells treated with a CRISPR gRNA against SEC62. (SEC62-BGKcLV33-39)


ENCODE biosample ENCBS068UAP

characteristic: External Id

text: ENCODE

text: live

text: Generic

text: 15 year

characteristic: age

characteristic: cell line

text: Homo sapiens HepG2 cell line genetically modified (deletion) using CRISPR targeting H. sapiens CNOT2

characteristic: description

text: child

characteristic: dev stage

characteristic: donor ID

text: hepatocellular carcinoma

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

text: male

text: ATCC

text: ENCODE biosample ENCBS068UAP: RNA-seq on HepG2 cells treated with a CRISPR gRNA against CNOT2. (CNOT2-BGHcLV24-22)

characteristic: title


ENCODE biosample ENCBS069FLE

text: ENCODE

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Generic

text: 90 or above year

text: Homo sapiens female adult (90 or above years) with mild cognitive impairment; middle frontal area 46 tissue

text: adult

text: Barbara Wold, Caltech

text: Homo sapiens

characteristic: organism

text: tissue

characteristic: sample type

text: female

characteristic: sex

text: Rush University

text: middle frontal area 46

text: ENCODE biosample ENCBS069FLE: human_brain_Rush ID_E9716765_BS218_ENC4_cDNA773


ENCODE biosample ENCBS069KUQ

text: ENCODE

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

text: 15 year

text: Homo sapiens HepG2 cell line genetically modified (deletion) using CRISPR targeting H. sapiens RPS8

text: child

text: hepatocellular carcinoma

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

text: male

text: ATCC

characteristic: source

text: ENCODE biosample ENCBS069KUQ: RNA-seq on HepG2 cells treated with a CRISPR gRNA against RPS8. (RPS8-BGHcLV31-10)


ENCODE biosample ENCBS071BUY

characteristic: External Id

text: ENCODE

text: live

text: Generic

characteristic: SRA accession

text: 25 year

characteristic: age

text: Homo sapiens Calu3 cell line treated with 500 rad irradiation

text: adult

text: Lung adenocarcinoma

characteristic: health state

text: Mats Ljungman, UMichigan

characteristic: lab

text: Homo sapiens

text: cell line

text: male

text: ATCC

text: ENCODE biosample ENCBS071BUY

text: treatment_term_name: irradiation; treatment_type: irradiation;

characteristic: treatments


ENCODE biosample ENCBS072RXM

text: ENCODE

characteristic: INSDC center name

text: live

text: Generic

text: 15 year

characteristic: cell line

text: Homo sapiens HepG2 cell line genetically modified (deletion) using CRISPR targeting H. sapiens CAND1

characteristic: description

text: child

characteristic: dev stage

characteristic: donor ID

text: hepatocellular carcinoma

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

text: male

text: ATCC

text: ENCODE biosample ENCBS072RXM: RNA-seq on HepG2 cells treated with a CRISPR gRNA against CAND1. (CAND1-BGHcLV27-33)

characteristic: title


ENCODE biosample ENCBS074AEV

text: ENCODE

characteristic: INSDC first public

characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

text: Generic

text: 58 year

text: Homo sapiens A549 cell line treated with 1 uM ZK216348 (agonist) for 4 hours

text: adult

text: Tim Reddy, Duke

text: Homo sapiens

characteristic: organism

text: cell line

characteristic: sample type

text: male

characteristic: sex

text: ATCC

text: ENCODE biosample ENCBS074AEV

text: treatment_term_name: ZK216348; treatment_type: chemical; duration: 4; duration_units: hour;


ENCODE biosample ENCBS075IEY

characteristic: External Id

text: ENCODE

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

characteristic: SRA accession

text: 90 or above year

text: Homo sapiens female adult (90 or above years) middle frontal area 46 tissue

text: adult

text: Barbara Wold, Caltech

text: Homo sapiens

text: tissue

text: female

text: Rush University

characteristic: source

text: middle frontal area 46

characteristic: tissue

text: ENCODE biosample ENCBS075IEY: human_brain_Rush ID_3453103_BS49_ENC4_cDNA649


ENCODE biosample ENCBS075VXO

text: ENCODE

characteristic: INSDC center name

text: live

text: Generic

text: 50 year

characteristic: age

text: T-helper 17 cell

characteristic: cell type

text: Homo sapiens male adult (50 years) T-helper 17 primary cell

characteristic: description

text: adult

text: John Stamatoyannopoulos, UW

characteristic: lab

text: Homo sapiens

text: primary cell

text: male

text: StemExpress

text: ENCODE biosample ENCBS075VXO


ENCODE biosample ENCBS075YII

text: ENCODE

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Generic

text: 72 year

characteristic: cell line

text: Homo sapiens Caco-2 cell line

text: adult

characteristic: dev stage

characteristic: donor ID

text: colorectal adenocarcinoma

characteristic: health state

text: Mats Ljungman, UMichigan

text: Homo sapiens

text: cell line

text: male

text: ATCC

text: ENCODE biosample ENCBS075YII

characteristic: title


ENCODE biosample ENCBS076KCC

characteristic: External Id

text: ENCODE

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

text: 58 year

text: Homo sapiens A549 cell line treated with 1 uM CpdA (agonist) for 4 hours

text: adult

text: Tim Reddy, Duke

text: Homo sapiens

characteristic: organism

text: cell line

characteristic: sample type

text: male

characteristic: sex

text: ATCC

text: ENCODE biosample ENCBS076KCC

text: treatment_term_name: CpdA; treatment_type: chemical; duration: 4; duration_units: hour;

characteristic: treatments


ENCODE biosample ENCBS077ZEW

text: ENCODE

characteristic: INSDC center name

text: live

text: Generic

characteristic: NCBI submission package

characteristic: SRA accession

text: 86 year

characteristic: age

text: Homo sapiens male adult (86 years) middle frontal area 46 tissue

characteristic: description

text: adult

text: Barbara Wold, Caltech

text: Homo sapiens

text: tissue

text: male

text: Rush University

characteristic: source

text: middle frontal area 46

characteristic: tissue

text: ENCODE biosample ENCBS077ZEW: human_brain_Rush ID_E8895621_BS185_ENC4_cDNA739


ENCODE biosample ENCBS081HJW

text: ENCODE

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Generic

text: 48 year

characteristic: cell line

text: Homo sapiens HCT116 cell line genetically modified (insertion) using CRISPR inserting O. sativa LOC4335696, genetically modified (insertion) using CRISPR targeting H. sapiens SUPT16H treated with 1 uM 5-Phenyl-1H-indole-3-acetic acid for 6 hours

text: adult

characteristic: dev stage

characteristic: donor ID

text: colorectal carcinoma

characteristic: health state

text: Erez Aiden, Baylor

characteristic: lab

text: Homo sapiens

text: cell line

text: male

text: Dr. Masato Kanemaki

text: ENCODE biosample ENCBS081HJW

text: treatment_term_name: 5-Phenyl-1H-indole-3-acetic acid; treatment_type: chemical; duration: 6; duration_units: hour;


ENCODE biosample ENCBS082OUT

characteristic: External Id

text: ENCODE

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

text: 53 year

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens AHCYL2

text: adult

text: chronic myelogenous leukemia (CML)

text: Brenton Graveley, UConn

text: Homo sapiens

characteristic: organism

text: cell line

characteristic: sample type

text: female

text: ATCC

text: ENCODE biosample ENCBS082OUT: RNA-seq on K562 cells treated with a CRISPR gRNA against AHCYL2. (AHCYL2-BGKcLV26-18)

characteristic: title


ENCODE biosample ENCBS083RVQ

text: ENCODE

characteristic: INSDC center name

text: live

text: Generic

characteristic: NCBI submission package

characteristic: SRA accession

text: 15 year

characteristic: age

text: Homo sapiens HepG2 cell line genetically modified (deletion) using CRISPR targeting H. sapiens RNASEH2A

characteristic: description

text: child

text: hepatocellular carcinoma

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

text: male

characteristic: sex

text: ATCC

text: ENCODE biosample ENCBS083RVQ: RNA-seq on HepG2 cells treated with a CRISPR gRNA against RNASEH2A. (RNASEH2A-BGHcLV32-36)


ENCODE biosample ENCBS084LOL

text: ENCODE

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Generic

text: 53 year

characteristic: cell line

text: Homo sapiens K562 cell line treated with 10 uM Crizotinib for 4 hours, preserved by flash-freezing

text: adult

characteristic: dev stage

text: chronic myelogenous leukemia (CML)

text: Will Greenleaf, Stanford

text: Homo sapiens

text: cell line

text: female

text: ATCC

characteristic: source

text: ENCODE biosample ENCBS084LOL: RNA-seq on human cell line K562

text: treatment_term_name: Crizotinib; treatment_type: chemical; duration: 4; duration_units: hour; temperature: 37; temperature_units: Celsius;

characteristic: treatments


ENCODE biosample ENCBS084MWU

characteristic: External Id

text: ENCODE

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

text: 15 year

text: Homo sapiens HepG2 cell line genetically modified (deletion) using CRISPR targeting H. sapiens ALDOA

text: child

characteristic: donor ID

text: hepatocellular carcinoma

characteristic: health state

text: Brenton Graveley, UConn

characteristic: lab

text: Homo sapiens

text: cell line

text: male

text: ATCC

text: ENCODE biosample ENCBS084MWU: RNA-seq on HepG2 cells treated with a CRISPR gRNA against ALDOA. (ALDOA-BGHcLV27-8)


ENCODE biosample ENCBS085BKT

text: ENCODE

characteristic: INSDC center name

text: live

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

text: 53 year

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens SMG8

text: adult

text: chronic myelogenous leukemia (CML)

text: Brenton Graveley, UConn

text: Homo sapiens

characteristic: organism

text: cell line

characteristic: sample type

text: female

text: ATCC

text: ENCODE biosample ENCBS085BKT: RNA-seq on K562 cells treated with a CRISPR gRNA against SMG5. (SMG5-BGKcLV33-55)

characteristic: title


ENCODE biosample ENCBS086OWN

text: ENCODE

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Generic

characteristic: SRA accession

text: 90 or above year

characteristic: age

text: Homo sapiens female adult (90 or above years) middle frontal area 46 tissue

characteristic: description

text: adult

text: Barbara Wold, Caltech

text: Homo sapiens

text: tissue

text: female

characteristic: sex

text: Rush University

text: middle frontal area 46

characteristic: tissue

text: ENCODE biosample ENCBS086OWN: human_brain_Rush ID_E7461192_BS73


ENCODE biosample ENCBS087MBA

characteristic: External Id

text: ENCODE

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

text: 53 year

characteristic: cell line

text: Homo sapiens K562 cell line treated with 1% DMSO for 48 hours, preserved by flash-freezing

text: adult

characteristic: dev stage

text: chronic myelogenous leukemia (CML)

text: Will Greenleaf, Stanford

text: Homo sapiens

text: cell line

text: female

text: ATCC

characteristic: source

text: ENCODE biosample ENCBS087MBA: RNA-seq on human cell line K562

text: treatment_term_name: DMSO; treatment_type: chemical; duration: 48; duration_units: hour; temperature: 37; temperature_units: Celsius;

characteristic: treatments


ENCODE biosample ENCBS087PCF

text: ENCODE

characteristic: INSDC center name

text: live

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

text: 58 year

text: Homo sapiens A549 cell line treated with 1 uM GW870086 (agonist) for 4 hours

text: adult

characteristic: donor ID

text: Tim Reddy, Duke

characteristic: lab

text: Homo sapiens

characteristic: organism

text: cell line

text: male

text: ATCC

text: ENCODE biosample ENCBS087PCF

text: treatment_term_name: GW870086; treatment_type: chemical; duration: 4; duration_units: hour;


ENCODE biosample ENCBS089TXQ

text: ENCODE

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Generic

characteristic: SRA accession

text: 53 year

characteristic: age

text: Homo sapiens K562 cell line treated with 5 uM JQ1 for 48 hours, preserved by flash-freezing

text: adult

text: chronic myelogenous leukemia (CML)

characteristic: health state

text: Will Greenleaf, Stanford

text: Homo sapiens

text: cell line

characteristic: sample type

text: female

text: ATCC

text: ENCODE biosample ENCBS089TXQ: RNA-seq on human cell line K562

characteristic: title

text: treatment_term_name: JQ1; treatment_type: chemical; duration: 48; duration_units: hour; temperature: 37; temperature_units: Celsius;


ENCODE biosample ENCBS092QEJ

characteristic: External Id

text: ENCODE

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

text: 15 year

characteristic: cell line

text: Homo sapiens HepG2 cell line genetically modified (deletion) using CRISPR targeting H. sapiens RUVBL1

characteristic: description

text: child

text: hepatocellular carcinoma

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

text: male

characteristic: sex

text: ATCC

text: ENCODE biosample ENCBS092QEJ: RNA-seq on HepG2 cells treated with a CRISPR gRNA against RUVBL1. (RUVBL1-BGHcLV31-20)


ENCODE biosample ENCBS093CJI

text: ENCODE

characteristic: INSDC center name

text: live

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

text: 48 year

text: Homo sapiens HCT116 cell line genetically modified (insertion) using CRISPR inserting O. sativa LOC4335696, genetically modified (insertion) using CRISPR targeting H. sapiens SUPT16H treated with 1 uM 5-Phenyl-1H-indole-3-acetic acid for 6 hours

text: adult

characteristic: dev stage

text: colorectal carcinoma

text: Erez Aiden, Baylor

text: Homo sapiens

text: cell line

text: male

text: Dr. Masato Kanemaki

characteristic: source

text: ENCODE biosample ENCBS093CJI

text: treatment_term_name: 5-Phenyl-1H-indole-3-acetic acid; treatment_type: chemical; duration: 6; duration_units: hour;

characteristic: treatments


ENCODE biosample ENCBS094EUX

text: ENCODE

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Generic

characteristic: SRA accession

text: 15 year

text: Homo sapiens HepG2 cell line genetically modified (deletion) using CRISPR targeting H. sapiens CTTN

text: child

characteristic: donor ID

text: hepatocellular carcinoma

text: Brenton Graveley, UConn

characteristic: lab

text: Homo sapiens

characteristic: organism

text: cell line

text: male

text: ATCC

text: ENCODE biosample ENCBS094EUX: RNA-seq on HepG2 cells treated with a CRISPR gRNA against CTTN. (CTTN-BGHcLV29-51)


ENCODE biosample ENCBS094KCL

characteristic: External Id

text: ENCODE

characteristic: INSDC secondary accession

text: live

text: Generic

text: 53 year

characteristic: age

text: adult

text: chronic myelogenous leukemia (CML)

characteristic: health state

text: Will Greenleaf, Stanford

text: Homo sapiens

text: cell line

characteristic: sample type

text: female

text: ATCC

text: ENCODE biosample ENCBS094KCL: RNA-seq on human cell line K562

characteristic: title


ENCODE biosample ENCBS096ZMQ

text: ENCODE

characteristic: INSDC center name

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

text: 53 year

characteristic: cell line

text: Homo sapiens K562 cell line treated with 10 uM AR-42 for 24 hours, preserved by flash-freezing

characteristic: description

text: adult

text: chronic myelogenous leukemia (CML)

text: Will Greenleaf, Stanford

text: Homo sapiens

text: cell line

text: female

characteristic: sex

text: ATCC

text: ENCODE biosample ENCBS096ZMQ: RNA-seq on human cell line K562

text: treatment_term_name: AR-42; treatment_type: chemical; duration: 24; duration_units: hour; temperature: 37; temperature_units: Celsius;


ENCODE biosample ENCBS097DNB

text: ENCODE

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Generic

characteristic: NCBI submission package

text: 15 year

text: Homo sapiens HepG2 cell line genetically modified (deletion) using CRISPR targeting H. sapiens C1QBP

text: child

characteristic: dev stage

text: hepatocellular carcinoma

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

text: male

text: ATCC

characteristic: source

text: ENCODE biosample ENCBS097DNB: RNA-seq on HepG2 cells treated with a CRISPR gRNA against C1QBP. (C1QBP-BGHcLV27-31)


ENCODE biosample ENCBS097LDJ

characteristic: External Id

text: ENCODE

text: live

text: Generic

characteristic: SRA accession

text: 15 year

text: Homo sapiens HepG2 cell line genetically modified (deletion) using CRISPR targeting H. sapiens DDX18

text: child

characteristic: donor ID

text: hepatocellular carcinoma

text: Brenton Graveley, UConn

characteristic: lab

text: Homo sapiens

characteristic: organism

text: cell line

text: male

text: ATCC

text: ENCODE biosample ENCBS097LDJ: RNA-seq on HepG2 cells treated with a CRISPR gRNA against DDX18. (DDX18-BGHcLV29-71)


ENCODE biosample ENCBS098LQT

text: ENCODE

characteristic: INSDC secondary accession

text: live

text: Generic

text: 53 year

characteristic: age

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens ARHGEF2

text: adult

text: chronic myelogenous leukemia (CML)

characteristic: health state

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

characteristic: sample type

text: female

text: ATCC

text: ENCODE biosample ENCBS098LQT: RNA-seq on K562 cells treated with a CRISPR gRNA against ARHGEF2. (ARHGEF2-BGKcLV26-32)

characteristic: title


ENCODE biosample ENCBS098OWP

text: ENCODE

characteristic: INSDC center name

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

text: 53 year

characteristic: cell line

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens RPS9

characteristic: description

text: adult

text: chronic myelogenous leukemia (CML)

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

text: female

text: ATCC

text: ENCODE biosample ENCBS098OWP: RNA-seq on K562 cells treated with a CRISPR gRNA against CDC42EP4. (CDC42EP4-BGKcLV33-8)


ENCODE biosample ENCBS099LSY

text: ENCODE

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Generic

characteristic: NCBI submission package

text: 53 year

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens CD3EAP

text: adult

characteristic: dev stage

text: chronic myelogenous leukemia (CML)

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

text: female

characteristic: sex

text: ATCC

text: ENCODE biosample ENCBS099LSY: RNA-seq on K562 cells treated with a CRISPR gRNA against CD3EAP. (CD3EAP-BGKcLV28-10)


ENCODE biosample ENCBS099NKE

characteristic: External Id

text: ENCODE

text: live

text: Generic

characteristic: SRA accession

text: 53 year

text: Homo sapiens K562 cell line treated with 1% DMSO for 24 hours, preserved by flash-freezing

text: adult

characteristic: donor ID

text: chronic myelogenous leukemia (CML)

text: Will Greenleaf, Stanford

characteristic: lab

text: Homo sapiens

text: cell line

text: female

text: ATCC

characteristic: source

text: ENCODE biosample ENCBS099NKE: RNA-seq on human cell line K562

text: treatment_term_name: DMSO; treatment_type: chemical; duration: 24; duration_units: hour; temperature: 37; temperature_units: Celsius;

characteristic: treatments


ENCODE biosample ENCBS101AYX

text: ENCODE

characteristic: INSDC secondary accession

text: live

text: Generic

text: 47 year

characteristic: age

text: motor neuron

characteristic: cell type

text: Homo sapiens male adult (47 years) motor neuron in vitro differentiated cells, preserved by flash-freezing

text: adult

text: Donor with Amyotrophic Lateral Sclerosis

characteristic: health state

text: Michael Snyder, Stanford

text: Homo sapiens

characteristic: organism

text: in vitro differentiated cells

characteristic: sample type

text: male

text: Cooper-Knock lab, University of Sheffield, UK

text: ENCODE biosample ENCBS101AYX: RNA-seq on human

characteristic: title


ENCODE biosample ENCBS103UWX

text: ENCODE

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

text: 58 year

characteristic: cell line

text: Homo sapiens A549 cell line treated with 1 uM CORT108297 (agonist) for 4 hours

characteristic: description

text: adult

text: Tim Reddy, Duke

text: Homo sapiens

text: cell line

text: male

text: ATCC

text: ENCODE biosample ENCBS103UWX

text: treatment_term_name: CORT108297; treatment_type: chemical; duration: 4; duration_units: hour;


ENCODE biosample ENCBS104KVQ

characteristic: External Id

text: ENCODE

text: live

text: Generic

characteristic: NCBI submission package

characteristic: SRA accession

text: 15 year

text: Homo sapiens HepG2 cell line genetically modified (deletion) using CRISPR targeting H. sapiens CARS

text: child

characteristic: dev stage

characteristic: donor ID

text: hepatocellular carcinoma

text: Brenton Graveley, UConn

characteristic: lab

text: Homo sapiens

text: cell line

text: male

characteristic: sex

text: ATCC

text: ENCODE biosample ENCBS104KVQ: RNA-seq on HepG2 cells treated with a CRISPR gRNA against CARS. (CARS-BGHcLV27-40)


ENCODE biosample ENCBS105DDE

text: ENCODE

characteristic: INSDC secondary accession

text: live

text: Generic

text: 88 year

characteristic: age

text: Homo sapiens female adult (88 years) middle frontal area 46 tissue

text: adult

text: Barbara Wold, Caltech

text: Homo sapiens

characteristic: organism

text: tissue

text: female

text: Rush University

characteristic: source

text: middle frontal area 46

characteristic: tissue

text: ENCODE biosample ENCBS105DDE: human_brain_Rush ID_5115600_BS16_ENC4_cDNA653


ENCODE biosample ENCBS111LHN

text: ENCODE

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Generic

text: 53 year

text: Homo sapiens K562 cell line treated with 7.5 nM Vorinostat for 48 hours, preserved by flash-freezing

text: adult

text: chronic myelogenous leukemia (CML)

characteristic: health state

text: Will Greenleaf, Stanford

text: Homo sapiens

text: cell line

characteristic: sample type

text: female

text: ATCC

text: ENCODE biosample ENCBS111LHN: RNA-seq on human cell line K562

characteristic: title

text: treatment_term_name: Vorinostat; treatment_type: chemical; duration: 48; duration_units: hour; temperature: 37; temperature_units: Celsius;

characteristic: treatments


ENCODE biosample ENCBS111RUU

characteristic: External Id

text: ENCODE

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

characteristic: SRA accession

text: 58 year

characteristic: cell line

text: Homo sapiens A549 cell line treated with 1 uM Hydrocortisone (agonist) for 4 hours

characteristic: description

text: adult

text: Tim Reddy, Duke

text: Homo sapiens

text: cell line

text: male

text: ATCC

text: ENCODE biosample ENCBS111RUU

text: treatment_term_id: CHEBI:17650; treatment_term_name: Hydrocortisone; treatment_type: chemical; duration: 4; duration_units: hour;


ENCODE biosample ENCBS112LRL

text: ENCODE

characteristic: INSDC secondary accession

text: live

text: Generic

text: 72 year

characteristic: age

text: Homo sapiens Caco-2 cell line, subjected to a 6 hour pulse-chase

text: adult

characteristic: dev stage

characteristic: donor ID

text: colorectal adenocarcinoma

text: Mats Ljungman, UMichigan

characteristic: lab

text: Homo sapiens

characteristic: organism

text: cell line

text: male

characteristic: sex

text: ATCC

text: ENCODE biosample ENCBS112LRL


ENCODE biosample ENCBS112SEO

text: ENCODE

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Generic

text: 48 year

text: Homo sapiens OCI-LY7 cell line

text: adult

text: B cell lymphoma

characteristic: health state

text: Mats Ljungman, UMichigan

text: Homo sapiens

text: cell line

characteristic: sample type

text: male

text: DSMZ

characteristic: source

text: ENCODE biosample ENCBS112SEO


ENCODE biosample ENCBS114KZO

characteristic: External Id

text: ENCODE

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

text: 30 year

text: Homo sapiens WTC11 cell line, preserved by flash-freezing

text: adult

text: Will Greenleaf, Stanford

text: Homo sapiens

text: cell line

text: male

text: Coriell

text: ENCODE biosample ENCBS114KZO: iPSC

characteristic: title


ENCODE biosample ENCBS114TMY

text: ENCODE

characteristic: INSDC secondary accession

text: live

text: Generic

characteristic: SRA accession

text: 58 year

characteristic: age

characteristic: cell line

characteristic: description

text: adult

text: Tim Reddy, Duke

text: Homo sapiens

text: cell line

text: male

text: ATCC

text: ENCODE biosample ENCBS114TMY

characteristic: treatments


ENCODE biosample ENCBS114ZTO

text: ENCODE

characteristic: INSDC center name

text: live

text: Generic

text: 53 year

text: Homo sapiens K562 cell line treated with 10 nM Bortezomib for 12 hours, preserved by flash-freezing

text: adult

characteristic: dev stage

characteristic: donor ID

text: chronic myelogenous leukemia (CML)

text: Will Greenleaf, Stanford

characteristic: lab

text: Homo sapiens

characteristic: organism

text: cell line

text: female

characteristic: sex

text: ATCC

text: ENCODE biosample ENCBS114ZTO: RNA-seq on human cell line K562

text: treatment_term_id: CHEBI:52717; treatment_term_name: Bortezomib; treatment_type: chemical; duration: 12; duration_units: hour; temperature: 37; temperature_units: Celsius;


ENCODE biosample ENCBS115RPO

characteristic: External Id

text: ENCODE

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Generic

text: 58 year

text: Homo sapiens A549 cell line treated with 1 uM Mapracorat (agonist) for 4 hours

text: adult

text: Tim Reddy, Duke

text: Homo sapiens

text: cell line

characteristic: sample type

text: male

text: ATCC

characteristic: source

text: ENCODE biosample ENCBS115RPO

text: treatment_term_id: CHEBI:177650; treatment_term_name: Mapracorat; treatment_type: chemical; duration: 4; duration_units: hour;


ENCODE biosample ENCBS117WPK

text: ENCODE

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

text: 47 year

text: natural killer cell

characteristic: cell type

text: Homo sapiens male adult (47 years) natural killer primary cell

text: adult

text: John Stamatoyannopoulos, UW

text: Homo sapiens

text: primary cell

text: male

text: StemExpress

text: ENCODE biosample ENCBS117WPK

characteristic: title


ENCODE biosample ENCBS119KBU

text: ENCODE

characteristic: INSDC center name

text: live

text: Generic

characteristic: SRA accession

text: 53 year

characteristic: age

characteristic: cell line

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens CCT3

characteristic: description

text: adult

text: chronic myelogenous leukemia (CML)

characteristic: health state

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

text: female

text: ATCC

text: ENCODE biosample ENCBS119KBU: RNA-seq on K562 cells treated with a CRISPR gRNA against CCT3. (CCT3-BGKcLV28-6)


ENCODE biosample ENCBS119YVC

characteristic: External Id

text: ENCODE

text: live

text: Generic

text: 48 year

text: Homo sapiens HCT116 cell line genetically modified (insertion) using CRISPR inserting O. sativa LOC4335696, genetically modified (insertion) using CRISPR targeting H. sapiens CDK7 treated with 1 uM 5-Phenyl-1H-indole-3-acetic acid for 6 hours

text: adult

characteristic: dev stage

characteristic: donor ID

text: colorectal carcinoma

text: Erez Aiden, Baylor

characteristic: lab

text: Homo sapiens

characteristic: organism

text: cell line

text: male

characteristic: sex

text: Dr. Masato Kanemaki

text: ENCODE biosample ENCBS119YVC

text: treatment_term_name: 5-Phenyl-1H-indole-3-acetic acid; treatment_type: chemical; duration: 6; duration_units: hour;

characteristic: treatments


ENCODE biosample ENCBS120DQN

text: ENCODE

characteristic: INSDC first public

characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

text: 80 year

text: Homo sapiens male adult (80 years) with Cognitive impairment, Alzheimer's disease; middle frontal area 46 tissue

text: adult

text: Barbara Wold, Caltech

text: Homo sapiens

text: tissue

characteristic: sample type

text: male

text: Rush University

characteristic: source

text: middle frontal area 46

characteristic: tissue

text: ENCODE biosample ENCBS120DQN: human_brain_Rush ID_E2504543_BS178_ENC4_cDNA732


ENCODE biosample ENCBS122JGP

text: ENCODE

characteristic: INSDC center name

text: live

text: Generic

characteristic: NCBI submission package

characteristic: SRA accession

text: 58 year

characteristic: age

characteristic: cell line

characteristic: description

text: adult

text: Tim Reddy, Duke

text: Homo sapiens

text: cell line

text: male

text: ATCC

text: ENCODE biosample ENCBS122JGP

characteristic: title


ENCODE biosample ENCBS125VHW

characteristic: External Id

text: ENCODE

text: live

text: Generic

text: 15 year

text: Homo sapiens HepG2 cell line

text: child

characteristic: dev stage

characteristic: donor ID

text: hepatocellular carcinoma

characteristic: health state

text: Brenton Graveley, UConn

characteristic: lab

text: Homo sapiens

characteristic: organism

text: cell line

text: male

characteristic: sex

text: ATCC

text: ENCODE biosample ENCBS125VHW: Control CRISPR gRNA against no target in HepG2 cells followed by RNA-seq. (NT-BGHcLV29-1)


ENCODE biosample ENCBS126IJD

text: ENCODE

characteristic: INSDC first public

characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

text: 53 year

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens SAP30BP

text: adult

text: chronic myelogenous leukemia (CML)

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

characteristic: sample type

text: female

text: ATCC

text: ENCODE biosample ENCBS126IJD: RNA-seq on K562 cells treated with a CRISPR gRNA against RUVBL1. (RUVBL1-BGKcLV33-24)


ENCODE biosample ENCBS126MYE

text: ENCODE

characteristic: INSDC center name

text: live

text: Generic

characteristic: NCBI submission package

characteristic: SRA accession

text: 53 year

characteristic: age

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens CLNS1A

text: adult

text: chronic myelogenous leukemia (CML)

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

text: female

text: ATCC

characteristic: source

text: ENCODE biosample ENCBS126MYE: RNA-seq on K562 cells treated with a CRISPR gRNA against CLNS1A. (CLNS1A-BGKcLV28-21)


ENCODE biosample ENCBS127CGY

characteristic: External Id

text: ENCODE

text: live

text: Generic

text: 90 or above year

text: Homo sapiens female adult (90 or above years) with Alzheimer's disease; middle frontal area 46 tissue

characteristic: description

text: adult

characteristic: dev stage

text: Barbara Wold, Caltech

text: Homo sapiens

text: tissue

text: female

text: Rush University

text: middle frontal area 46

characteristic: tissue

text: ENCODE biosample ENCBS127CGY: human_brain_Rush ID_E3348003_BS71

characteristic: title


ENCODE biosample ENCBS127UZI

text: ENCODE

text: live

text: Generic

text: 6 year

text: motor neuron

characteristic: cell type

text: Homo sapiens male child (6 years) motor neuron in vitro differentiated cells, preserved by flash-freezing

text: child

characteristic: donor ID

text: Healthy donor

characteristic: health state

text: Michael Snyder, Stanford

characteristic: lab

text: Homo sapiens

characteristic: organism

text: in vitro differentiated cells

text: male

characteristic: sex

text: Cooper-Knock lab, University of Sheffield, UK

text: ENCODE biosample ENCBS127UZI: RNA-seq on human


ENCODE biosample ENCBS128QWT

text: ENCODE

characteristic: INSDC first public

characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

text: 53 year

characteristic: cell line

text: Homo sapiens K562 cell line treated with 7.5 nM Vorinostat for 12 hours, preserved by flash-freezing

text: adult

text: chronic myelogenous leukemia (CML)

text: Will Greenleaf, Stanford

text: Homo sapiens

text: cell line

characteristic: sample type

text: female

text: ATCC

text: ENCODE biosample ENCBS128QWT: RNA-seq on human cell line K562

text: treatment_term_name: Vorinostat; treatment_type: chemical; duration: 12; duration_units: hour; temperature: 37; temperature_units: Celsius;

characteristic: treatments


ENCODE biosample ENCBS129MBJ

characteristic: External Id

text: ENCODE

characteristic: INSDC center name

text: live

text: Generic

characteristic: NCBI submission package

characteristic: SRA accession

text: 53 year

characteristic: age

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens CHCHD3

characteristic: description

text: adult

characteristic: dev stage

text: chronic myelogenous leukemia (CML)

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

text: female

text: ATCC

characteristic: source

text: ENCODE biosample ENCBS129MBJ: RNA-seq on K562 cells treated with a CRISPR gRNA against CHCHD3. (CHCHD3-BGKcLV28-17)


ENCODE biosample ENCBS129NMG

text: ENCODE

text: live

text: Generic

text: 90 or above year

text: Homo sapiens female adult (90 or above years) with mild cognitive impairment; middle frontal area 46 tissue

text: adult

characteristic: donor ID

text: Barbara Wold, Caltech

characteristic: lab

text: Homo sapiens

characteristic: organism

text: tissue

text: female

characteristic: sex

text: Rush University

text: middle frontal area 46

characteristic: tissue

text: ENCODE biosample ENCBS129NMG: human_brain_Rush ID_E4638217_BS98_ENC4_cDNA675

characteristic: title


ENCODE biosample ENCBS131BON

text: ENCODE

characteristic: INSDC first public

characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

text: 15 year

characteristic: cell line

text: Homo sapiens HepG2 cell line genetically modified (deletion) using CRISPR targeting H. sapiens RNH1

text: child

text: hepatocellular carcinoma

characteristic: health state

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

text: male

text: ATCC

text: ENCODE biosample ENCBS131BON: RNA-seq on HepG2 cells treated with a CRISPR gRNA against RNH1. (RNH1-BGHcLV32-37)


ENCODE biosample ENCBS135ECM

characteristic: External Id

text: ENCODE

characteristic: INSDC center name

text: live

text: Generic

characteristic: NCBI submission package

characteristic: SRA accession

text: 87 year

characteristic: age

text: Homo sapiens female adult (87 years) middle frontal area 46 tissue

text: adult

text: Barbara Wold, Caltech

text: Homo sapiens

text: tissue

characteristic: sample type

text: female

text: Rush University

text: middle frontal area 46

text: ENCODE biosample ENCBS135ECM: human_brain_Rush ID_E9835349_BS192_ENC4_cDNA746


ENCODE biosample ENCBS136FWL

text: ENCODE

text: live

text: Generic

text: 53 year

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens ACO2

characteristic: description

text: adult

characteristic: dev stage

characteristic: donor ID

text: chronic myelogenous leukemia (CML)

text: Brenton Graveley, UConn

characteristic: lab

text: Homo sapiens

characteristic: organism

text: cell line

text: female

text: ATCC

characteristic: source

text: ENCODE biosample ENCBS136FWL: RNA-seq on K562 cells treated with a CRISPR gRNA against ACO2. (ACO2-BGKcLV26-4)


ENCODE biosample ENCBS136YMV

text: ENCODE

characteristic: INSDC first public

characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

text: Generic

text: motor neuron

characteristic: cell type

text: Homo sapiens female adult motor neuron in vitro differentiated cells, preserved by flash-freezing

text: adult

text: Healthy donor

text: Michael Snyder, Stanford

text: Homo sapiens

text: in vitro differentiated cells

text: female

characteristic: sex

text: ENCODE biosample ENCBS136YMV: RNA-seq on human

characteristic: title


ENCODE biosample ENCBS137FIF

characteristic: External Id

text: ENCODE

characteristic: INSDC center name

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

text: 53 year

characteristic: cell line

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens CAT

text: adult

text: chronic myelogenous leukemia (CML)

characteristic: health state

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

text: female

text: ATCC

text: ENCODE biosample ENCBS137FIF: RNA-seq on K562 cells treated with a CRISPR gRNA against CAT. (CAT-BGKcLV26-61)


ENCODE biosample ENCBS137SYN

text: ENCODE

text: live

text: Generic

characteristic: NCBI submission package

characteristic: SRA accession

text: 83 year

characteristic: age

text: Homo sapiens male adult (83 years) middle frontal area 46 tissue

characteristic: description

text: adult

characteristic: dev stage

text: Barbara Wold, Caltech

text: Homo sapiens

text: tissue

characteristic: sample type

text: male

text: Rush University

text: middle frontal area 46

characteristic: tissue

text: ENCODE biosample ENCBS137SYN: human_brain_Rush ID_E1182310_BS120_ENC4_cDNA682


ENCODE biosample ENCBS137YOG

text: ENCODE

characteristic: INSDC first public

characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

text: Generic

text: 15 year

text: Homo sapiens HepG2 cell line genetically modified (deletion) using CRISPR targeting H. sapiens CPSF4

text: child

characteristic: donor ID

text: hepatocellular carcinoma

text: Brenton Graveley, UConn

characteristic: lab

text: Homo sapiens

characteristic: organism

text: cell line

text: male

text: ATCC

characteristic: source

text: ENCODE biosample ENCBS137YOG: RNA-seq on HepG2 cells treated with a CRISPR gRNA against CPSF4. (CPSF4-BGHcLV24-24)


ENCODE biosample ENCBS138CBR

characteristic: External Id

text: ENCODE

characteristic: INSDC center name

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

text: 53 year

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens ALDH18A1

text: adult

text: chronic myelogenous leukemia (CML)

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

text: female

characteristic: sex

text: ATCC

text: ENCODE biosample ENCBS138CBR: RNA-seq on K562 cells treated with a CRISPR gRNA against ALDH18A1. (ALDH18A1-BGKcLV26-22)

characteristic: title


ENCODE biosample ENCBS139ZBT

text: ENCODE

text: live

text: Generic

characteristic: NCBI submission package

characteristic: SRA accession

text: 30 year

characteristic: age

characteristic: cell line

text: Homo sapiens WTC11 cell line treated with 7.5 uM CHIR 99021 for 24 hours, 1 day post differentiation, preserved by flash-freezing

characteristic: description

text: adult

text: Will Greenleaf, Stanford

text: Homo sapiens

text: cell line

text: male

text: Coriell

text: ENCODE biosample ENCBS139ZBT: iPSC differentiation in to cardiomycytes

text: treatment_term_id: CHEBI:91091; treatment_term_name: CHIR 99021; treatment_type: chemical; duration: 24; duration_units: hour;

characteristic: treatments


ENCODE biosample ENCBS140SWH

text: ENCODE

characteristic: INSDC first public

characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

text: Generic

text: 53 year

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens CSNK1E

text: adult

characteristic: dev stage

text: chronic myelogenous leukemia (CML)

characteristic: health state

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

characteristic: sample type

text: female

text: ATCC

text: ENCODE biosample ENCBS140SWH: RNA-seq on K562 cells treated with a CRISPR gRNA against CSNK1E. (CSNK1E-BGKcLV28-45)


ENCODE biosample ENCBS141BGY

characteristic: External Id

text: ENCODE

characteristic: INSDC center name

text: live

text: Generic

text: 48 year

text: Homo sapiens HCT116 cell line genetically modified (insertion) using CRISPR inserting O. sativa LOC4335696, genetically modified (insertion) using CRISPR targeting H. sapiens SMARCA5

text: adult

characteristic: donor ID

text: colorectal carcinoma

text: Erez Aiden, Baylor

characteristic: lab

text: Homo sapiens

characteristic: organism

text: cell line

text: male

text: Dr. Masato Kanemaki

characteristic: source

text: ENCODE biosample ENCBS141BGY


ENCODE biosample ENCBS141EMN

text: ENCODE

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

characteristic: SRA accession

text: 90 or above year

text: Homo sapiens female adult (90 or above years) with Alzheimer's disease; middle frontal area 46 tissue

text: adult

text: Barbara Wold, Caltech

text: Homo sapiens

text: tissue

text: female

characteristic: sex

text: Rush University

text: middle frontal area 46

characteristic: tissue

text: ENCODE biosample ENCBS141EMN: human_brain_Rush ID_E4781406_BS151_ENC4_cDNA701

characteristic: title


ENCODE biosample ENCBS142BAL

text: ENCODE

characteristic: INSDC first public

characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

text: Generic

text: 53 year

characteristic: age

characteristic: cell line

text: Homo sapiens K562 cell line treated with 10 nM Bortezomib for 12 hours, preserved by flash-freezing

characteristic: description

text: adult

text: chronic myelogenous leukemia (CML)

text: Will Greenleaf, Stanford

text: Homo sapiens

text: cell line

text: female

text: ATCC

text: ENCODE biosample ENCBS142BAL: RNA-seq on human cell line K562

text: treatment_term_id: CHEBI:52717; treatment_term_name: Bortezomib; treatment_type: chemical; duration: 12; duration_units: hour; temperature: 37; temperature_units: Celsius;

characteristic: treatments


ENCODE biosample ENCBS142IPM

characteristic: External Id

text: ENCODE

characteristic: INSDC center name

text: live

text: Generic

text: 48 year

text: Homo sapiens HCT116 cell line genetically modified (insertion) using CRISPR inserting O. sativa LOC4335696, genetically modified (insertion) using CRISPR targeting H. sapiens SUPT16H treated with 1 uM 5-Phenyl-1H-indole-3-acetic acid for 6 hours

text: adult

characteristic: dev stage

characteristic: donor ID

text: colorectal carcinoma

characteristic: health state

text: Erez Aiden, Baylor

characteristic: lab

text: Homo sapiens

text: cell line

characteristic: sample type

text: male

text: Dr. Masato Kanemaki

text: ENCODE biosample ENCBS142IPM

text: treatment_term_name: 5-Phenyl-1H-indole-3-acetic acid; treatment_type: chemical; duration: 6; duration_units: hour;


ENCODE biosample ENCBS143QQX

text: ENCODE

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

characteristic: SRA accession

text: 48 year

text: Homo sapiens HCT116 cell line genetically modified (insertion) using CRISPR inserting O. sativa LOC4335696, genetically modified (insertion) using CRISPR targeting H. sapiens CDK7 treated with 1 uM 5-Phenyl-1H-indole-3-acetic acid for 6 hours

text: adult

text: colorectal carcinoma

text: Erez Aiden, Baylor

text: Homo sapiens

characteristic: organism

text: cell line

text: male

characteristic: sex

text: Dr. Masato Kanemaki

characteristic: source

text: ENCODE biosample ENCBS143QQX


ENCODE biosample ENCBS143SBN

text: ENCODE

characteristic: INSDC first public

characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

text: Generic

text: 15 year

characteristic: age

characteristic: cell line

text: Homo sapiens HepG2 cell line genetically modified (deletion) using CRISPR

text: child

text: hepatocellular carcinoma

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

text: male

text: ATCC

text: ENCODE biosample ENCBS143SBN: Control CRISPR gRNA against no target in HepG2 cells followed by RNA-seq. (NT-BGHcLV31-2)

characteristic: title


ENCODE biosample ENCBS144VMS

characteristic: External Id

text: ENCODE

characteristic: INSDC center name

text: live

text: Generic

text: 15 year

text: Homo sapiens HepG2 cell line genetically modified (deletion) using CRISPR targeting H. sapiens CAND1

characteristic: description

text: child

characteristic: dev stage

characteristic: donor ID

text: hepatocellular carcinoma

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

text: male

text: ATCC

text: ENCODE biosample ENCBS144VMS: RNA-seq on HepG2 cells treated with a CRISPR gRNA against CAND1. (CAND1-BGHcLV27-34)


ENCODE biosample ENCBS146JAV

text: ENCODE

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

text: 53 year

text: Homo sapiens K562 cell line treated with 7.5 nM Panobinostat for 48 hours, preserved by flash-freezing

text: adult

text: chronic myelogenous leukemia (CML)

characteristic: health state

text: Will Greenleaf, Stanford

characteristic: lab

text: Homo sapiens

text: cell line

characteristic: sample type

text: female

text: ATCC

text: ENCODE biosample ENCBS146JAV: RNA-seq on human cell line K562

text: treatment_term_name: Panobinostat; treatment_type: chemical; duration: 48; duration_units: hour; temperature: 37; temperature_units: Celsius;

characteristic: treatments


ENCODE biosample ENCBS151HDI

text: ENCODE

characteristic: INSDC first public

text: live

text: Generic

characteristic: NCBI submission package

characteristic: SRA accession

text: 58 year

text: Homo sapiens A549 cell line treated with 1 uM Mapracorat (agonist) for 4 hours

text: adult

text: Tim Reddy, Duke

text: Homo sapiens

characteristic: organism

text: cell line

text: male

characteristic: sex

text: ATCC

characteristic: source

text: ENCODE biosample ENCBS151HDI

text: treatment_term_id: CHEBI:177650; treatment_term_name: Mapracorat; treatment_type: chemical; duration: 4; duration_units: hour;


ENCODE biosample ENCBS154EVT

characteristic: External Id

text: ENCODE

characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

text: Generic

text: 53 year

characteristic: age

characteristic: cell line

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens CDV3

text: adult

text: chronic myelogenous leukemia (CML)

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

text: female

text: ATCC

text: ENCODE biosample ENCBS154EVT: RNA-seq on K562 cells treated with a CRISPR gRNA against CDV3. (CDV3-BGKcLV28-15)

characteristic: title


ENCODE biosample ENCBS154MMU

text: ENCODE

characteristic: INSDC center name

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

text: 53 year

text: Homo sapiens K562 cell line

characteristic: description

text: adult

characteristic: dev stage

characteristic: donor ID

text: chronic myelogenous leukemia (CML)

text: John Lis, Cornell

text: Homo sapiens

text: cell line

text: female

text: ATCC

text: ENCODE biosample ENCBS154MMU


ENCODE biosample ENCBS154QKL

text: ENCODE

characteristic: INSDC first public

text: live

text: Generic

characteristic: NCBI submission package

text: 15 year

text: Homo sapiens HepG2 cell line genetically modified (deletion) using CRISPR targeting H. sapiens CMTR1

text: child

text: hepatocellular carcinoma

characteristic: health state

text: Brenton Graveley, UConn

characteristic: lab

text: Homo sapiens

text: cell line

characteristic: sample type

text: male

text: ATCC

text: ENCODE biosample ENCBS154QKL: RNA-seq on HepG2 cells treated with a CRISPR gRNA against CMTR1. (CMTR1-BGHcLV29-26)


ENCODE biosample ENCBS155PQE

characteristic: External Id

text: ENCODE

text: live

text: Generic

characteristic: SRA accession

text: 15 year

text: Homo sapiens A673 cell line, subjected to a 6 hour pulse-chase

text: child

text: Mats Ljungman, UMichigan

text: Homo sapiens

characteristic: organism

text: cell line

text: female

characteristic: sex

text: ATCC

characteristic: source

text: ENCODE biosample ENCBS155PQE


ENCODE biosample ENCBS156BEM

text: ENCODE

characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

text: Generic

text: 48 year

characteristic: age

characteristic: cell line

text: Homo sapiens HCT116 cell line genetically modified (insertion) using CRISPR inserting O. sativa LOC4335696, genetically modified (insertion) using CRISPR targeting H. sapiens BRD4 treated with 1 uM 5-Phenyl-1H-indole-3-acetic acid for 6 hours

text: adult

text: colorectal carcinoma

text: Erez Aiden, Baylor

text: Homo sapiens

text: cell line

text: male

text: Dr. Masato Kanemaki

text: ENCODE biosample ENCBS156BEM

characteristic: title

characteristic: treatments


ENCODE biosample ENCBS156HXW

text: ENCODE

characteristic: INSDC center name

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

text: 15 year

text: Homo sapiens HepG2 cell line genetically modified (deletion) using CRISPR targeting H. sapiens RTCB

characteristic: description

text: child

characteristic: dev stage

characteristic: donor ID

text: hepatocellular carcinoma

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

text: male

text: ATCC

text: ENCODE biosample ENCBS156HXW: RNA-seq on HepG2 cells treated with a CRISPR gRNA against RTCB. (RTCB-BGHcLV31-18)


ENCODE biosample ENCBS158GLY

characteristic: External Id

text: ENCODE

characteristic: INSDC first public

text: live

text: Generic

characteristic: NCBI submission package

text: 53 year

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens ARHGEF2

text: adult

text: chronic myelogenous leukemia (CML)

characteristic: health state

text: Brenton Graveley, UConn

characteristic: lab

text: Homo sapiens

text: cell line

characteristic: sample type

text: female

text: ATCC

text: ENCODE biosample ENCBS158GLY: RNA-seq on K562 cells treated with a CRISPR gRNA against ARHGEF2. (ARHGEF2-BGKcLV26-31)


ENCODE biosample ENCBS159MAA

text: ENCODE

characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

text: Generic

characteristic: SRA accession

text: 90 or above year

text: Homo sapiens female adult (90 or above years) with mild cognitive impairment; middle frontal area 46 tissue

text: adult

text: Barbara Wold, Caltech

text: Homo sapiens

characteristic: organism

text: tissue

text: female

characteristic: sex

text: Rush University

characteristic: source

text: middle frontal area 46

characteristic: tissue

text: ENCODE biosample ENCBS159MAA: human_brain_Rush ID_E9254359_BS216_ENC4_cDNA771


ENCODE biosample ENCBS161BVI

text: ENCODE

characteristic: INSDC center name

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

text: endothelial cell of umbilical vein

characteristic: cell type

text: Homo sapiens male newborn endothelial of umbilical vein primary cell

text: newborn

text: Mats Ljungman, UMichigan

text: Homo sapiens

text: primary cell

text: male

text: Lonza

text: ENCODE biosample ENCBS161BVI

characteristic: title


ENCODE biosample ENCBS164SOA

characteristic: External Id

text: ENCODE

characteristic: INSDC first public

text: live

text: Generic

text: 30 year

characteristic: age

characteristic: cell line

text: Homo sapiens WTC11 cell line, preserved by flash-freezing

characteristic: description

text: adult

characteristic: dev stage

characteristic: donor ID

text: Will Greenleaf, Stanford

text: Homo sapiens

text: cell line

text: male

text: Coriell

text: ENCODE biosample ENCBS164SOA: iPSC


ENCODE biosample ENCBS166GKO

text: ENCODE

characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

text: Generic

characteristic: NCBI submission package

characteristic: SRA accession

text: 85 year

text: Homo sapiens female adult (85 years) middle frontal area 46 tissue

text: adult

text: Barbara Wold, Caltech

characteristic: lab

text: Homo sapiens

text: tissue

characteristic: sample type

text: female

text: Rush University

text: middle frontal area 46

text: ENCODE biosample ENCBS166GKO: human_brain_Rush ID_E2728434_BS149_ENC4_cDNA749


ENCODE biosample ENCBS166ZET

text: ENCODE

characteristic: INSDC center name

text: live

characteristic: INSDC status

text: Generic

text: 53 year

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens ALDOA

text: adult

text: chronic myelogenous leukemia (CML)

characteristic: health state

text: Brenton Graveley, UConn

text: Homo sapiens

characteristic: organism

text: cell line

text: female

characteristic: sex

text: ATCC

characteristic: source

text: ENCODE biosample ENCBS166ZET: RNA-seq on K562 cells treated with a CRISPR gRNA against ALDOA. (ALDOA-BGKcLV26-23)


ENCODE biosample ENCBS167CPD

characteristic: External Id

text: ENCODE

characteristic: INSDC first public

text: live

text: Generic

characteristic: NCBI submission model

text: 30 year

characteristic: age

text: adult

text: Will Greenleaf, Stanford

text: Homo sapiens

text: cell line

text: male

text: Coriell

text: ENCODE biosample ENCBS167CPD: iPSC

characteristic: title


ENCODE biosample ENCBS167JZF

text: ENCODE

characteristic: INSDC last update

text: live

text: Generic

text: 15 year

characteristic: cell line

text: Homo sapiens HepG2 cell line genetically modified (deletion) using CRISPR targeting H. sapiens ELAC2

characteristic: description

text: child

characteristic: dev stage

characteristic: donor ID

text: hepatocellular carcinoma

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

text: male

text: ATCC

text: ENCODE biosample ENCBS167JZF: RNA-seq on HepG2 cells treated with a CRISPR gRNA against ELAC2. (ELAC2-BGHcLV24-31)


ENCODE biosample ENCBS167SHL

text: ENCODE

characteristic: INSDC secondary accession

text: live

text: Generic

characteristic: NCBI submission package

characteristic: SRA accession

text: 53 year

text: Homo sapiens K562 cell line

text: adult

text: chronic myelogenous leukemia (CML)

text: John Lis, Cornell

characteristic: lab

text: Homo sapiens

text: cell line

characteristic: sample type

text: female

text: ATCC

text: ENCODE biosample ENCBS167SHL


ENCODE biosample ENCBS168DEU

text: ENCODE

characteristic: INSDC center name

text: live

characteristic: INSDC status

text: Generic

text: 36 year

text: MCF 10A

text: Homo sapiens MCF 10A cell line, subjected to a 2 hour pulse-chase

text: adult

text: fibrocystic disease

characteristic: health state

text: Mats Ljungman, UMichigan

text: Homo sapiens

characteristic: organism

text: cell line

text: female

characteristic: sex

text: ATCC

text: ENCODE biosample ENCBS168DEU


ENCODE biosample ENCBS168FVU

characteristic: External Id

text: ENCODE

characteristic: INSDC first public

text: live

text: Generic

characteristic: NCBI submission model

text: 83 year

characteristic: age

text: Homo sapiens female adult (83 years) middle frontal area 46 tissue

text: adult

text: Barbara Wold, Caltech

text: Homo sapiens

text: tissue

text: female

text: Rush University

characteristic: source

text: middle frontal area 46

characteristic: tissue

text: ENCODE biosample ENCBS168FVU: human_brain_Rush ID_E1488495_BS121_ENC4_cDNA683


ENCODE biosample ENCBS170BGM

text: ENCODE

characteristic: INSDC last update

text: live

text: Generic

text: 53 year

characteristic: cell line

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens CMTR1

characteristic: description

text: adult

characteristic: dev stage

characteristic: donor ID

text: chronic myelogenous leukemia (CML)

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

text: female

text: ATCC

text: ENCODE biosample ENCBS170BGM: RNA-seq on K562 cells treated with a CRISPR gRNA against CMTR1. (CMTR1-BGKcLV28-26)

characteristic: title


ENCODE biosample ENCBS172RKT

text: ENCODE

characteristic: INSDC center name

characteristic: INSDC secondary accession

text: live

text: Generic

characteristic: NCBI submission package

characteristic: SRA accession

text: 53 year

text: Homo sapiens K562 cell line treated with 5 uM JQ1 for 12 hours, preserved by flash-freezing

text: adult

text: chronic myelogenous leukemia (CML)

text: Will Greenleaf, Stanford

characteristic: lab

text: Homo sapiens

text: cell line

characteristic: sample type

text: female

text: ATCC

text: ENCODE biosample ENCBS172RKT: RNA-seq on human cell line K562

text: treatment_term_name: JQ1; treatment_type: chemical; duration: 12; duration_units: hour; temperature: 37; temperature_units: Celsius;

characteristic: treatments


ENCODE biosample ENCBS172TZS

characteristic: External Id

text: ENCODE

characteristic: INSDC first public

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

text: 36 year

text: Homo sapiens HL-60 cell line treated with 10 uM phorbol 13-acetate 12-myristate for 120 hours, 10 ng/mL interleukin-13 for 24 hours, 10 ng/mL interleukin-4 for 24 hours

text: adult

text: acute promyelocytic leukemia

characteristic: health state

text: Ali Mortazavi, UCI

text: Homo sapiens

characteristic: organism

text: cell line

text: female

characteristic: sex

text: ATCC

text: ENCODE biosample ENCBS172TZS: HL-60 derived M2A macrophages (24hr)

text: treatment_term_id: CHEBI:37537; treatment_term_name: phorbol 13-acetate 12-myristate; treatment_type: chemical; duration: 120; duration_units: hour; treatment_term_id: UniProtKB:P35225; treatment_term_name: interleukin-13; treatment_type: protein; duration: 24; duration_units: hour; treatment_term_id: UniProtKB:P05112; treatment_term_name: interleukin-4; treatment_type: protein; duration: 24; duration_units: hour;


ENCODE biosample ENCBS173FOK

text: ENCODE

characteristic: INSDC last update

text: live

text: Generic

text: 53 year

characteristic: age

characteristic: cell line

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens SEC31A

characteristic: description

text: adult

characteristic: dev stage

text: chronic myelogenous leukemia (CML)

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

text: female

text: ATCC

characteristic: source

text: ENCODE biosample ENCBS173FOK: RNA-seq on K562 cells treated with a CRISPR gRNA against SARNP. (SARNP-BGKcLV33-32)


ENCODE biosample ENCBS174HKA

text: ENCODE

characteristic: INSDC center name

characteristic: INSDC secondary accession

text: live

text: Generic

characteristic: NCBI submission package

characteristic: SRA accession

text: 15 year

text: Homo sapiens HepG2 cell line genetically modified (deletion) using CRISPR targeting H. sapiens CPSF2

text: child

characteristic: donor ID

text: hepatocellular carcinoma

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

text: male

text: ATCC

text: ENCODE biosample ENCBS174HKA: RNA-seq on HepG2 cells treated with a CRISPR gRNA against CPSF2. (CPSF2-BGHcLV29-33)

characteristic: title


ENCODE biosample ENCBS174IZH

characteristic: External Id

text: ENCODE

characteristic: INSDC first public

text: live

characteristic: INSDC status

text: Generic

text: 53 year

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens RPRD1B

text: adult

text: chronic myelogenous leukemia (CML)

text: Brenton Graveley, UConn

characteristic: lab

text: Homo sapiens

text: cell line

characteristic: sample type

text: female

text: ATCC

text: ENCODE biosample ENCBS174IZH: RNA-seq on K562 cells treated with a CRISPR gRNA against RPRD1B. (RPRD1B-BGKcLV30-60)


ENCODE biosample ENCBS176FEN

text: ENCODE

characteristic: INSDC last update

text: live

text: Generic

characteristic: NCBI submission model

text: 19 year

text: mammary epithelial cell

characteristic: cell type

text: Homo sapiens female adult (19 years) mammary epithelial primary cell treated with 500 rad irradiation

text: adult

text: Mats Ljungman, UMichigan

text: Homo sapiens

characteristic: organism

text: primary cell

text: female

characteristic: sex

text: Lonza

text: ENCODE biosample ENCBS176FEN

text: treatment_term_name: irradiation; treatment_type: irradiation;

characteristic: treatments


ENCODE biosample ENCBS177AWD

text: ENCODE

characteristic: INSDC center name

text: live

text: Generic

text: 74 year

characteristic: age

text: Homo sapiens female adult (74 years) with Alzheimer's disease; middle frontal area 46 tissue

characteristic: description

text: adult

characteristic: dev stage

text: Barbara Wold, Caltech

text: Homo sapiens

text: tissue

text: female

text: Rush University

characteristic: source

text: middle frontal area 46

characteristic: tissue

text: ENCODE biosample ENCBS177AWD: human_brain_Rush ID_E2501226_BS144_ENC4_cDNA694


ENCODE biosample ENCBS179KFU

characteristic: External Id

text: ENCODE

characteristic: INSDC secondary accession

text: live

text: Generic

characteristic: NCBI submission package

characteristic: SRA accession

text: 85 year

text: Homo sapiens female adult (85 years) middle frontal area 46 tissue

text: adult

characteristic: donor ID

text: Barbara Wold, Caltech

text: Homo sapiens

text: tissue

text: female

text: Rush University

text: middle frontal area 46

text: ENCODE biosample ENCBS179KFU: human_brain_Rush ID_2705751_BS113_ENC4_cDNA663

characteristic: title


ENCODE biosample ENCBS180JSX

text: ENCODE

characteristic: INSDC first public

characteristic: INSDC last update

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

text: 30 year

characteristic: cell line

text: Homo sapiens WTC11 cell line, 6 days post differentiation, preserved by flash-freezing

text: adult

text: Will Greenleaf, Stanford

characteristic: lab

text: Homo sapiens

text: cell line

characteristic: sample type

text: male

text: Coriell

text: ENCODE biosample ENCBS180JSX: iPSC differentiation in to cardiomycytes


ENCODE biosample ENCBS183DAH

text: ENCODE

characteristic: INSDC center name

text: live

text: Generic

text: 53 year

characteristic: age

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens CDC5L

characteristic: description

text: adult

text: chronic myelogenous leukemia (CML)

characteristic: health state

text: Brenton Graveley, UConn

text: Homo sapiens

characteristic: organism

text: cell line

text: female

characteristic: sex

text: ATCC

text: ENCODE biosample ENCBS183DAH: RNA-seq on K562 cells treated with a CRISPR gRNA against CDC5L. (CDC5L-BGKcLV28-11)


ENCODE biosample ENCBS185KSH

characteristic: External Id

text: ENCODE

characteristic: INSDC secondary accession

text: live

text: Generic

characteristic: NCBI submission package

text: 15 year

text: Homo sapiens HepG2 cell line genetically modified (deletion) using CRISPR targeting H. sapiens BRIX1

text: child

characteristic: dev stage

text: hepatocellular carcinoma

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

text: male

text: ATCC

characteristic: source

text: ENCODE biosample ENCBS185KSH: RNA-seq on HepG2 cells treated with a CRISPR gRNA against BRIX1. (BRIX1-BGHcLV24-19)


ENCODE biosample ENCBS186ADK

text: ENCODE

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Generic

characteristic: SRA accession

text: 90 or above year

text: Homo sapiens female adult (90 or above years) with mild cognitive impairment; middle frontal area 46 tissue

text: adult

characteristic: donor ID

text: Barbara Wold, Caltech

text: Homo sapiens

text: tissue

text: female

text: Rush University

text: middle frontal area 46

characteristic: tissue

text: ENCODE biosample ENCBS186ADK: human_brain_Rush ID_E5410646_BS203_ENC4_cDNA758

characteristic: title


ENCODE biosample ENCBS186RPN

text: ENCODE

characteristic: INSDC center name

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

text: 53 year

characteristic: cell line

text: Homo sapiens K562 cell line treated with 1% DMSO for 12 hours, preserved by flash-freezing

text: adult

text: chronic myelogenous leukemia (CML)

text: Will Greenleaf, Stanford

characteristic: lab

text: Homo sapiens

text: cell line

characteristic: sample type

text: female

text: ATCC

text: ENCODE biosample ENCBS186RPN: RNA-seq on human cell line K562

text: treatment_term_name: DMSO; treatment_type: chemical; duration: 12; duration_units: hour; temperature: 37; temperature_units: Celsius;

characteristic: treatments


ENCODE biosample ENCBS188GNU

characteristic: External Id

text: ENCODE

characteristic: INSDC secondary accession

text: live

text: Generic

text: 15 year

characteristic: age

text: Homo sapiens HepG2 cell line genetically modified (deletion) using CRISPR targeting H. sapiens RIOK2

characteristic: description

text: child

text: hepatocellular carcinoma

characteristic: health state

text: Brenton Graveley, UConn

text: Homo sapiens

characteristic: organism

text: cell line

text: male

characteristic: sex

text: ATCC

text: ENCODE biosample ENCBS188GNU: RNA-seq on HepG2 cells treated with a CRISPR gRNA against RIOK2. (RIOK2-BGHcLV32-33B)


ENCODE biosample ENCBS188SIQ

text: ENCODE

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Generic

characteristic: NCBI submission package

characteristic: SRA accession

text: 53 year

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens DDX23

text: adult

characteristic: dev stage

characteristic: donor ID

text: chronic myelogenous leukemia (CML)

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

text: female

text: ATCC

characteristic: source

text: ENCODE biosample ENCBS188SIQ: RNA-seq on K562 cells treated with a CRISPR gRNA against DDX23. (DDX23-BGKcLV28-73)


ENCODE biosample ENCBS190GEP

text: ENCODE

characteristic: INSDC center name

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

text: 53 year

characteristic: cell line

text: Homo sapiens K562 cell line treated with 100 nM GSK J4 for 24 hours, preserved by flash-freezing

text: adult

text: chronic myelogenous leukemia (CML)

text: Will Greenleaf, Stanford

characteristic: lab

text: Homo sapiens

text: cell line

text: female

text: ATCC

text: ENCODE biosample ENCBS190GEP: RNA-seq on human cell line K562

characteristic: title

text: treatment_term_name: GSK J4; treatment_type: chemical; duration: 24; duration_units: hour; temperature: 37; temperature_units: Celsius;


ENCODE biosample ENCBS190LXS

characteristic: External Id

text: ENCODE

characteristic: INSDC secondary accession

text: live

text: Generic

text: 90 or above year

characteristic: age

text: Homo sapiens male adult (90 or above years) with mild cognitive impairment; middle frontal area 46 tissue

characteristic: description

text: adult

text: Barbara Wold, Caltech

text: Homo sapiens

text: tissue

characteristic: sample type

text: male

text: Rush University

text: middle frontal area 46

characteristic: tissue

text: ENCODE biosample ENCBS190LXS: human_brain_Rush ID_E3253149_BS96_ENC4_cDNA673


ENCODE biosample ENCBS190MRQ

text: ENCODE

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Generic

characteristic: NCBI submission package

text: 33 year

text: natural killer cell

characteristic: cell type

text: Homo sapiens male adult (33 years) natural killer primary cell

text: adult

text: Yijun Ruan, JAX

text: Homo sapiens

characteristic: organism

text: primary cell

text: male

characteristic: sex

text: AllCells

text: ENCODE biosample ENCBS190MRQ


ENCODE biosample ENCBS191ARH

text: ENCODE

characteristic: INSDC center name

text: live

characteristic: INSDC status

text: Generic

characteristic: SRA accession

text: 48 year

text: Homo sapiens HCT116 cell line genetically modified (insertion) using CRISPR inserting O. sativa LOC4335696, genetically modified (insertion) using CRISPR targeting H. sapiens BRD4 treated with 1 uM 5-Phenyl-1H-indole-3-acetic acid for 6 hours

text: adult

characteristic: dev stage

characteristic: donor ID

text: colorectal carcinoma

characteristic: health state

text: Erez Aiden, Baylor

text: Homo sapiens

text: cell line

text: male

text: Dr. Masato Kanemaki

characteristic: source

text: ENCODE biosample ENCBS191ARH

text: treatment_term_name: 5-Phenyl-1H-indole-3-acetic acid; treatment_type: chemical; duration: 6; duration_units: hour;

characteristic: treatments


ENCODE biosample ENCBS193FMX

characteristic: External Id

text: ENCODE

characteristic: INSDC secondary accession

text: live

text: Generic

characteristic: NCBI submission model

text: 15 year

characteristic: age

characteristic: cell line

text: Homo sapiens HepG2 cell line genetically modified (deletion) using CRISPR targeting H. sapiens CLTC

characteristic: description

text: child

text: hepatocellular carcinoma

text: Brenton Graveley, UConn

characteristic: lab

text: Homo sapiens

text: cell line

text: male

text: ATCC

text: ENCODE biosample ENCBS193FMX: RNA-seq on HepG2 cells treated with a CRISPR gRNA against CLTC. (CLTC-BGHcLV29-24)

characteristic: title


ENCODE biosample ENCBS195FGT

text: ENCODE

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Generic

characteristic: NCBI submission package

text: 36 year

text: Homo sapiens HL-60 cell line treated with 10 uM phorbol 13-acetate 12-myristate for 120 hours, 100 ng/mL interferon gamma for 24 hours, 100 ng/mL lipopolysaccharide for 24 hours

text: adult

text: acute promyelocytic leukemia

text: Ali Mortazavi, UCI

text: Homo sapiens

characteristic: organism

text: cell line

characteristic: sample type

text: female

characteristic: sex

text: ATCC

text: ENCODE biosample ENCBS195FGT: HL-60 derived M1 macrophages (24hr)

text: treatment_term_id: CHEBI:37537; treatment_term_name: phorbol 13-acetate 12-myristate; treatment_type: chemical; duration: 120; duration_units: hour; treatment_term_id: UniProtKB:P01579; treatment_term_name: interferon gamma; treatment_type: protein; duration: 24; duration_units: hour; treatment_term_id: CHEBI:16412; treatment_term_name: lipopolysaccharide; treatment_type: chemical; duration: 24; duration_units: hour;


ENCODE biosample ENCBS195ZYH

text: ENCODE

characteristic: INSDC center name

text: live

characteristic: INSDC status

text: Generic

characteristic: SRA accession

text: 15 year

text: Homo sapiens HepG2 cell line genetically modified (deletion) using CRISPR targeting H. sapiens LARS

text: child

characteristic: dev stage

characteristic: donor ID

text: hepatocellular carcinoma

characteristic: health state

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

text: male

text: ATCC

text: ENCODE biosample ENCBS195ZYH: RNA-seq on HepG2 cells treated with a CRISPR gRNA against LARS. (LARS-BGHcLV24-36)


ENCODE biosample ENCBS196EFF

characteristic: External Id

text: ENCODE

characteristic: INSDC secondary accession

text: live

text: Generic

characteristic: NCBI submission model

text: 53 year

characteristic: age

text: Homo sapiens K562 cell line treated with 7.5 nM Vorinostat for 24 hours, preserved by flash-freezing

text: adult

text: chronic myelogenous leukemia (CML)

text: Will Greenleaf, Stanford

text: Homo sapiens

text: cell line

text: female

text: ATCC

characteristic: source

text: ENCODE biosample ENCBS196EFF: RNA-seq on human cell line K562

text: treatment_term_name: Vorinostat; treatment_type: chemical; duration: 24; duration_units: hour; temperature: 37; temperature_units: Celsius;

characteristic: treatments


ENCODE biosample ENCBS197FRN

text: ENCODE

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Generic

text: 15 year

characteristic: cell line

text: Homo sapiens HepG2 cell line genetically modified (deletion) using CRISPR targeting H. sapiens CSTF3

characteristic: description

text: child

text: hepatocellular carcinoma

text: Brenton Graveley, UConn

characteristic: lab

text: Homo sapiens

text: cell line

text: male

text: ATCC

text: ENCODE biosample ENCBS197FRN: RNA-seq on HepG2 cells treated with a CRISPR gRNA against CSTF3. (CSTF3-BGHcLV29-47)

characteristic: title


ENCODE biosample ENCBS201TJP

text: ENCODE

characteristic: INSDC center name

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission package

text: 72 year

text: Homo sapiens Caco-2 cell line treated with 500 rad irradiation

text: adult

text: colorectal adenocarcinoma

text: Mats Ljungman, UMichigan

text: Homo sapiens

characteristic: organism

text: cell line

characteristic: sample type

text: male

characteristic: sex

text: ATCC

text: ENCODE biosample ENCBS201TJP

text: treatment_term_name: irradiation; treatment_type: irradiation;


ENCODE biosample ENCBS201ZQN

characteristic: External Id

text: ENCODE

characteristic: INSDC secondary accession

text: live

text: Generic

characteristic: SRA accession

text: 87 year

text: Homo sapiens male adult (87 years) with Alzheimer's disease; middle frontal area 46 tissue

text: adult

characteristic: dev stage

characteristic: donor ID

text: Barbara Wold, Caltech

text: Homo sapiens

text: tissue

text: male

text: Rush University

text: middle frontal area 46

characteristic: tissue

text: ENCODE biosample ENCBS201ZQN: human_brain_Rush ID_E4946143_BS152_ENC4_cDNA702


ENCODE biosample ENCBS202NAP

text: ENCODE

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Generic

characteristic: NCBI submission model

text: 53 year

characteristic: age

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens MTREX

text: adult

text: chronic myelogenous leukemia (CML)

characteristic: health state

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

text: female

text: ATCC

characteristic: source

text: ENCODE biosample ENCBS202NAP: RNA-seq on K562 cells treated with a CRISPR gRNA against SETD1A. (SETD1A-BGKcLV33-49)


ENCODE biosample ENCBS203SVC

text: ENCODE

characteristic: INSDC center name

text: live

characteristic: INSDC status

text: Generic

text: 15 year

characteristic: cell line

text: Homo sapiens HepG2 cell line genetically modified (deletion) using CRISPR targeting H. sapiens METTL1

characteristic: description

text: child

text: hepatocellular carcinoma

text: Brenton Graveley, UConn

characteristic: lab

text: Homo sapiens

text: cell line

text: male

text: ATCC

text: ENCODE biosample ENCBS203SVC: RNA-seq on HepG2 cells treated with a CRISPR gRNA against METTL1. (METTL1-BGHcLV24-37)

characteristic: title


ENCODE biosample ENCBS203UWG

characteristic: External Id

text: ENCODE

characteristic: INSDC secondary accession

text: live

text: Generic

characteristic: NCBI submission package

text: motor neuron

characteristic: cell type

text: Homo sapiens female adult motor neuron in vitro differentiated cells, preserved by flash-freezing

text: adult

text: Healthy donor

text: Michael Snyder, Stanford

text: Homo sapiens

characteristic: organism

text: in vitro differentiated cells

characteristic: sample type

text: female

characteristic: sex

text: Cooper-Knock lab, University of Sheffield, UK

text: ENCODE biosample ENCBS203UWG: RNA-seq on human


ENCODE biosample ENCBS204FBI

text: ENCODE

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Generic

characteristic: NCBI submission model

characteristic: SRA accession

text: 15 year

text: Homo sapiens HepG2 cell line genetically modified (deletion) using CRISPR targeting H. sapiens CSDE1

text: child

characteristic: dev stage

characteristic: donor ID

text: hepatocellular carcinoma

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

text: male

text: ATCC

text: ENCODE biosample ENCBS204FBI: RNA-seq on HepG2 cells treated with a CRISPR gRNA against CSDE1. (CSDE1-BGHcLV29-41)


ENCODE biosample ENCBS204HWF

text: ENCODE

characteristic: INSDC center name

text: live

characteristic: INSDC status

text: Generic

text: 81 year

characteristic: age

text: Homo sapiens female adult (81 years) with Alzheimer's disease; middle frontal area 46 tissue

text: adult

text: Barbara Wold, Caltech

text: Homo sapiens

text: tissue

text: female

text: Rush University

characteristic: source

text: middle frontal area 46

characteristic: tissue

text: ENCODE biosample ENCBS204HWF: human_brain_Rush ID_E8685549_BS169_ENC4_cDNA719


ENCODE biosample ENCBS208MUJ

characteristic: External Id

text: ENCODE

characteristic: INSDC secondary accession

text: live

text: Generic

text: 53 year

characteristic: cell line

text: Homo sapiens K562 cell line treated with 7.5 nM Vorinostat for 12 hours, preserved by flash-freezing

characteristic: description

text: adult

text: chronic myelogenous leukemia (CML)

characteristic: health state

text: Will Greenleaf, Stanford

characteristic: lab

text: Homo sapiens

text: cell line

text: female

text: ATCC

text: ENCODE biosample ENCBS208MUJ: RNA-seq on human cell line K562

characteristic: title

text: treatment_term_name: Vorinostat; treatment_type: chemical; duration: 12; duration_units: hour; temperature: 37; temperature_units: Celsius;

characteristic: treatments


ENCODE biosample ENCBS209BLC

text: ENCODE

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

text: 53 year

text: Homo sapiens K562 cell line treated with 10 uM Crizotinib for 4 hours, preserved by flash-freezing

text: adult

text: chronic myelogenous leukemia (CML)

text: Will Greenleaf, Stanford

text: Homo sapiens

characteristic: organism

text: cell line

characteristic: sample type

text: female

characteristic: sex

text: ATCC

text: ENCODE biosample ENCBS209BLC: RNA-seq on human cell line K562

text: treatment_term_name: Crizotinib; treatment_type: chemical; duration: 4; duration_units: hour; temperature: 37; temperature_units: Celsius;


ENCODE biosample ENCBS210FCU

text: ENCODE

characteristic: INSDC center name

text: live

characteristic: INSDC status

text: Generic

characteristic: SRA accession

text: 53 year

characteristic: age

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens RECQL5

text: adult

characteristic: dev stage

characteristic: donor ID

text: chronic myelogenous leukemia (CML)

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

text: female

text: ATCC

characteristic: source

text: ENCODE biosample ENCBS210FCU: RNA-seq on K562 cells treated with a CRISPR gRNA against RECQL5. (RECQL5-BGKcLV30-29)


ENCODE biosample ENCBS214JQO

characteristic: External Id

text: ENCODE

characteristic: INSDC secondary accession

text: live

text: Generic

text: 48 year

characteristic: cell line

text: Homo sapiens HCT116 cell line genetically modified (insertion) using CRISPR inserting O. sativa LOC4335696, genetically modified (insertion) using CRISPR targeting H. sapiens BRD4

characteristic: description

text: adult

text: colorectal carcinoma

characteristic: health state

text: Erez Aiden, Baylor

characteristic: lab

text: Homo sapiens

text: cell line

text: male

text: Dr. Masato Kanemaki

text: ENCODE biosample ENCBS214JQO


ENCODE biosample ENCBS216TDZ

text: ENCODE

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

text: 53 year

text: Homo sapiens K562 cell line treated with 5 uM JQ1 for 24 hours, preserved by flash-freezing

text: adult

text: chronic myelogenous leukemia (CML)

text: Will Greenleaf, Stanford

text: Homo sapiens

text: cell line

text: female

text: ATCC

text: ENCODE biosample ENCBS216TDZ: RNA-seq on human cell line K562

characteristic: title

text: treatment_term_name: JQ1; treatment_type: chemical; duration: 24; duration_units: hour; temperature: 37; temperature_units: Celsius;

characteristic: treatments


ENCODE biosample ENCBS218CMH

text: ENCODE

characteristic: INSDC center name

text: live

characteristic: INSDC status

text: Generic

characteristic: SRA accession

text: 53 year

text: Homo sapiens K562 cell line treated with 5 uM MB-3 for 48 hours, preserved by flash-freezing

text: adult

text: chronic myelogenous leukemia (CML)

text: Will Greenleaf, Stanford

text: Homo sapiens

characteristic: organism

text: cell line

characteristic: sample type

text: female

characteristic: sex

text: ATCC

text: ENCODE biosample ENCBS218CMH: RNA-seq on human cell line K562

text: treatment_term_name: MB-3; treatment_type: chemical; duration: 48; duration_units: hour; temperature: 37; temperature_units: Celsius;


ENCODE biosample ENCBS219MYC

characteristic: External Id

text: ENCODE

characteristic: INSDC secondary accession

text: live

text: Generic

text: 15 year

characteristic: age

text: Homo sapiens HepG2 cell line genetically modified (deletion) using CRISPR targeting H. sapiens BZW2

text: child

characteristic: dev stage

characteristic: donor ID

text: hepatocellular carcinoma

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

text: male

text: ATCC

characteristic: source

text: ENCODE biosample ENCBS219MYC: RNA-seq on HepG2 cells treated with a CRISPR gRNA against BZW2. (BZW2-BGHcLV27-29)


ENCODE biosample ENCBS222ZSB

text: ENCODE

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Generic

text: 48 year

text: activated T-helper 17 cell

characteristic: cell type

text: Homo sapiens male adult (48 years) activated T-helper 17 primary cell treated with 50 U/mL Interleukin-2 for 72 hours, anti-CD3 and anti-CD28 coated beads for 72 hours

characteristic: description

text: adult

text: John Stamatoyannopoulos, UW

characteristic: lab

text: Homo sapiens

text: primary cell

text: male

text: StemExpress

text: ENCODE biosample ENCBS222ZSB

text: treatment_term_id: UniProtKB:P60568; treatment_term_name: Interleukin-2; treatment_type: protein; duration: 72; duration_units: hour; treatment_term_name: anti-CD3 and anti-CD28 coated beads; treatment_type: antibody; duration: 72; duration_units: hour;


ENCODE biosample ENCBS223MNJ

text: ENCODE

characteristic: INSDC center name

text: live

text: Generic

characteristic: NCBI submission model

characteristic: NCBI submission package

text: 53 year

characteristic: cell line

text: Homo sapiens K562 cell line

text: adult

text: chronic myelogenous leukemia (CML)

characteristic: health state

text: John Lis, Cornell

text: Homo sapiens

text: cell line

text: female

text: ATCC

text: ENCODE biosample ENCBS223MNJ

characteristic: title


ENCODE biosample ENCBS223VKG

characteristic: External Id

text: ENCODE

text: live

characteristic: INSDC status

text: Generic

characteristic: SRA accession

text: 53 year

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens ADAT1

text: adult

text: chronic myelogenous leukemia (CML)

text: Brenton Graveley, UConn

text: Homo sapiens

characteristic: organism

text: cell line

characteristic: sample type

text: female

characteristic: sex

text: ATCC

text: ENCODE biosample ENCBS223VKG: RNA-seq on K562 cells treated with a CRISPR gRNA against ADAT1. (ADAT1-BGKcLV26-8)


ENCODE biosample ENCBS225NCG

text: ENCODE

characteristic: INSDC first public

characteristic: INSDC secondary accession

text: live

text: Generic

text: 53 year

characteristic: age

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR

text: adult

characteristic: dev stage

characteristic: donor ID

text: chronic myelogenous leukemia (CML)

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

text: female

text: ATCC

characteristic: source

text: ENCODE biosample ENCBS225NCG: Control CRISPR gRNA against no target in K562 cells followed by RNA-seq. (NT-BGKcLV28-2)


ENCODE biosample ENCBS226EPG

text: ENCODE

characteristic: INSDC center name

characteristic: INSDC last update

text: live

text: Generic

characteristic: NCBI submission model

text: 25 year

text: Homo sapiens Calu3 cell line, subjected to a 2 hour pulse-chase

characteristic: description

text: adult

text: Lung adenocarcinoma

text: Mats Ljungman, UMichigan

characteristic: lab

text: Homo sapiens

text: cell line

text: male

text: ATCC

text: ENCODE biosample ENCBS226EPG


ENCODE biosample ENCBS227PHU

characteristic: External Id

text: ENCODE

text: live

text: Generic

characteristic: NCBI submission package

text: 15 year

characteristic: cell line

text: Homo sapiens HepG2 cell line genetically modified (deletion) using CRISPR targeting H. sapiens SARNP

text: child

text: hepatocellular carcinoma

characteristic: health state

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

text: male

text: ATCC

text: ENCODE biosample ENCBS227PHU: RNA-seq on HepG2 cells treated with a CRISPR gRNA against SARNP. (SARNP-BGHcLV31-28)

characteristic: title


ENCODE biosample ENCBS228HSK

text: ENCODE

text: live

characteristic: INSDC status

text: Generic

characteristic: SRA accession

text: 53 year

text: Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting H. sapiens SRA1

text: adult

text: chronic myelogenous leukemia (CML)

text: Brenton Graveley, UConn

text: Homo sapiens

characteristic: organism

text: cell line

characteristic: sample type

text: female

characteristic: sex

text: ATCC

text: ENCODE biosample ENCBS228HSK: RNA-seq on K562 cells treated with a CRISPR gRNA against SPATS2. (SPATS2-BGKcLV33-69)


ENCODE biosample ENCBS234IIM

text: ENCODE

characteristic: INSDC first public

characteristic: INSDC secondary accession

text: live

text: Generic

text: 53 year

characteristic: age

text: adult

characteristic: dev stage

characteristic: donor ID

text: chronic myelogenous leukemia (CML)

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

text: female

text: ATCC

text: ENCODE biosample ENCBS234IIM: RNA-seq on K562 cells treated with a CRISPR gRNA against SRA1. (SRA1-BGKcLV33-73)


ENCODE biosample ENCBS236PDD

text: ENCODE

characteristic: INSDC center name

characteristic: INSDC last update

text: live

text: Generic

characteristic: NCBI submission model

text: 15 year

text: Homo sapiens HepG2 cell line genetically modified (deletion) using CRISPR targeting H. sapiens SEPT11

characteristic: description

text: child

text: hepatocellular carcinoma

text: Brenton Graveley, UConn

text: Homo sapiens

text: cell line

text: male

text: ATCC

characteristic: source

text: ENCODE biosample ENCBS236PDD: RNA-seq on HepG2 cells treated with a CRISPR gRNA against SEPT11. (SEPT11-BGHcLV31-42)